Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer
This study is currently recruiting participants.
Verified March 2013 by University of Kansas
Sponsor:
University of Kansas
Collaborators:
Novartis
GlaxoSmithKline
Information provided by (Responsible Party):
University of Kansas
ClinicalTrials.gov Identifier:
NCT01283789
First received: January 10, 2011
Last updated: March 27, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | May 2014 |
| Estimated Primary Completion Date: | November 2013 (Final data collection date for primary outcome measure) |